Connection

LAYLA ABUSHAMAT to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications LAYLA ABUSHAMAT has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease: Another Step Forward in This Lifelong Marathon. J Am Coll Cardiol. 2024 02 13; 83(6):665-668.
    View in: PubMed
    Score: 0.537
  2. Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care? J Am Coll Cardiol. 2023 04 11; 81(14):1350-1352.
    View in: PubMed
    Score: 0.506
  3. Lowering LDL cholesterol in clinical practice: time for change? Lancet. 2022 07 30; 400(10349):341-343.
    View in: PubMed
    Score: 0.481
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.